A patient is developing anaphylactic shock what should the nurse expect to observe in this patient

1. Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF, Jr, Bock SA, Branum A, et al. Second symposium on the definition and management of anaphylaxis: summary report—Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol. 2006;117:391–397. doi: 10.1016/j.jaci.2005.12.1303. [PubMed] [CrossRef] [Google Scholar]

2. Simons FER, Ardusso LR, Bilò M, Cardona V, Ebisawa M, El-Gamal YM, et al. International consensus on (ICON) anaphylaxis. World Allergy Organ J. 2014;7:9. doi: 10.1186/1939-4551-7-9. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

3. Muraro A, Roberts G, Worm M, Bilò MB, Brockow K, Fernández Rivas M, et al. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy. 2014;69:1026–1045. doi: 10.1111/all.12437. [PubMed] [CrossRef] [Google Scholar]

4. Lieberman P, Nicklas RA, Oppenheimer J, Kemp SF, Lang DM, Bernstein DI, et al. The diagnosis and management of anaphylaxis practice parameter: 2010 update. J Allergy Clin Immunol. 2010;126:442–477. doi: 10.1016/j.jaci.2010.06.022. [PubMed] [CrossRef] [Google Scholar]

5. Simons FER, Ardusso LRF, Bilò MB, El-Gamal YM, Ledford DK, Ring J, et al. World Allergy Organization guidelines for the assessment and management of anaphylaxis. World Allergy Organ J. 2011;4:13–37. doi: 10.1097/WOX.0b013e318211496c. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

6. Kastner M, Harada L, Waserman S. Gaps in anaphylaxis management at the level of physicians, patients, and the community: a systematic review of the literature. Allergy. 2010;65:435–444. doi: 10.1111/j.1398-9995.2009.02294.x. [PubMed] [CrossRef] [Google Scholar]

7. Wang J, Sicherer SH, Nowak-Wegrzyn A. Primary care physicians’ approach to food-induced anaphylaxis: a survey. J Allergy Clin Immunol. 2004;114:689–691. doi: 10.1016/j.jaci.2004.05.024. [PubMed] [CrossRef] [Google Scholar]

8. Krugman SD, Chiaramonte DR, Matsui EC. Diagnosis and management of food-induced anaphylaxis: a national survey of pediatricians. Pediatrics. 2006;118:e554–e560. doi: 10.1542/peds.2005-2906. [PubMed] [CrossRef] [Google Scholar]

9. Lowe G, Kirkwood E, Harkness S. Survey of anaphylaxis management by general practitioners in Scotland. Scott Med J. 2010;55:11–14. doi: 10.1258/rsmsmj.55.3.11. [PubMed] [CrossRef] [Google Scholar]

10. Erkoçoǧlu M, Civelek E, Azkur D, Özcan C, Öztürk K, Kaya A, et al. Knowledge and attitudes of primary care physicians regarding food allergy and anaphylaxis in Turkey. Allergol Immunopathol (Madr) 2013;41:292–297. doi: 10.1016/j.aller.2012.05.004. [PubMed] [CrossRef] [Google Scholar]

11. Baççioğlu A, Yilmazel Uçar E. Level of knowledge about anaphylaxis among health care providers. Tuberk Toraks. 2013;61:140–146. doi: 10.5578/tt.4812. [PubMed] [CrossRef] [Google Scholar]

12. Gómez Galán C, Ferré Ybarz L, Peña Peloche MA, Sansosti Viltes A, de la Borbolla Morán JM, Torredemer Palau A, et al. Intention to prescribe self-injectable epinephrine: are there differences depending on who assesses the patient post-reaction? Allergol Immunopathol (Madr) 2015;43:286–291. doi: 10.1016/j.aller.2014.03.003. [PubMed] [CrossRef] [Google Scholar]

13. Chung T, Gaudet L, Vandenberghe C, Couperthwaite S, Sookram S, Liss K, et al. Pre-hospital management of anaphylaxis in one Canadian Urban Centre. Resuscitation. 2014;85:1077–1082. doi: 10.1016/j.resuscitation.2014.04.004. [PubMed] [CrossRef] [Google Scholar]

14. Kimchi N, Clarke A, Moisan J, Lachaine C, La Vieille S, Asai Y, et al. Anaphylaxis cases presenting to primary care paramedics in Quebec. Immun Inflamm Dis. 2015;3:406–410. doi: 10.1002/iid3.78. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

15. Saleh-Langenberg J, Dubois AEJ, Groenhof F, Kocks JWH, van der Molen T, Flokstra-de Blok BMJ. Epinephrine auto-injector prescriptions to food-allergic patients in primary care in The Netherlands. Allergy Asthma Clin Immunol. 2015;11:28. doi: 10.1186/s13223-015-0094-9. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

16. Panesar SS, Javad S, De Silva D, Nwaru BI, Hickstein L, Muraro A, et al. The epidemiology of anaphylaxis in Europe: a systematic review. Allergy. 2013;68:1353–1361. doi: 10.1111/all.12272. [PubMed] [CrossRef] [Google Scholar]

17. Wood RA, Camargo CA, Lieberman P, Sampson HA, Schwartz LB, Zitt M, et al. Anaphylaxis in America: the prevalence and characteristics of anaphylaxis in the United States. J Allergy Clin Immunol. 2014;133:461–467. doi: 10.1016/j.jaci.2013.08.016. [PubMed] [CrossRef] [Google Scholar]

18. Tanno LK, Ganem F, Demoly P, Toscano CM, Bierrenbach AL. Undernotification of anaphylaxis deaths in Brazil due to difficult coding under the ICD-10. Allergy. 2012;67:783–789. doi: 10.1111/j.1398-9995.2012.02829.x. [PubMed] [CrossRef] [Google Scholar]

19. Tanno LK, Calderon MA, Goldberg BJ, Akdis CA, Papadopoulos NG, Demoly P. Categorization of allergic disorders in the new World Health Organization International Classification of Diseases. Clin Transl Allergy. 2014;4:42. doi: 10.1186/2045-7022-4-42. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

20. Moro Moro M, Tejedor Alonso MA, Esteban Hernandez J, Mugica Garcia MV, Rosado Ingelmo A, Vila Albelda C. Incidence of anaphylaxis and subtypes of anaphylaxis in a general hospital emergency department. J Invest Allergol Clin Immunol. 2011;21:142–149. [PubMed] [Google Scholar]

21. Smit DV, Cameron PA, Rainer TH. Anaphylaxis presentations to an emergency department in Hong Kong: incidence and predictors of biphasic reactions. J Emerg Med. 2005;28:381–388. doi: 10.1016/j.jemermed.2004.11.028. [PubMed] [CrossRef] [Google Scholar]

22. Bellou A, Manel J, Samman-Kaakaji H, de Korwin JD, Moneret-Vautrin DA, Bollaert PE, et al. Spectrum of acute allergic diseases in an emergency department: an evaluation of one years’ experience. Emerg Med. 2003;15:341–347. doi: 10.1046/j.1442-2026.2003.00472.x. [PubMed] [CrossRef] [Google Scholar]

23. Brown AF, McKinnon D, Chu K. Emergency department anaphylaxis: a review of 142 patients in a single year. J Allergy Clin Immunol. 2001;108:861–866. doi: 10.1067/mai.2001.119028. [PubMed] [CrossRef] [Google Scholar]

24. Campbell RL, Luke A, Weaver AL, St Sauver JL, Bergstralh EJ, Li JT, et al. Prescriptions for self-injectable epinephrine and follow-up referral in emergency department patients presenting with anaphylaxis. Ann Allergy Asthma Immunol. 2008;101:631–636. doi: 10.1016/S1081-1206(10)60227-X. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

25. Beyer K, Eckermann O, Hompes S, Grabenhenrich L, Worm M. Anaphylaxis in an emergency setting—elicitors, therapy and incidence of severe allergic reactions. Allergy. 2012;67:1451–1456. doi: 10.1111/all.12012. [PubMed] [CrossRef] [Google Scholar]

26. Cianferoni A, Novembre E, Mugnaini L, Lombardi E, Bernardini R, Pucci N, et al. Clinical features of acute anaphylaxis in patients admitted to a university hospital: an 11-year retrospective review (1985–1996) Ann Allergy Asthma Immunol. 2001;87:27–32. doi: 10.1016/S1081-1206(10)62318-6. [PubMed] [CrossRef] [Google Scholar]

27. Poachanukoon O, Paopairochanakorn C. Incidence of anaphylaxis in the emergency department: a 1-year study in a university hospital. Asian Pac J Allergy Immunol. 2006;24:111–116. [PubMed] [Google Scholar]

28. Alvarez-Perea A, Tomás-Pérez M, Martínez-Lezcano P, Marco G, Pérez D, Zubeldia JMM, et al. Anaphylaxis in adolescent/adult patients treated in the emergency department: differences between initial impressions and the definitive diagnosis. J Invest Allergol Clin Immunol. 2015;25:288–294. [PubMed] [Google Scholar]

29. Turner PJ, Gowland MH, Sharma V, Ierodiakonou D, Harper N, Garcez T, et al. Increase in anaphylaxis-related hospitalizations but no increase in fatalities: an analysis of United Kingdom national anaphylaxis data, 1992–2012. J Allergy Clin Immunol. 2015;135:956–963e1. doi: 10.1016/j.jaci.2014.10.021. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

30. Liew WK, Williamson E, Tang MLK. Anaphylaxis fatalities and admissions in Australia. J Allergy Clin Immunol. 2009;123:434–442. doi: 10.1016/j.jaci.2008.10.049. [PubMed] [CrossRef] [Google Scholar]

31. Tanno LK, Bierrenbach AL, Calderon MA, Sheikh A, Simons FER, Demoly P, et al. Decreasing the undernotification of anaphylaxis deaths in Brazil through the International Classification of Diseases (ICD)-11 revision. Allergy. 2017;72:120–125. doi: 10.1111/all.13006. [PubMed] [CrossRef] [Google Scholar]

32. Neugut AI, Ghatak AT, Miller RL. Anaphylaxis in the United States. Arch Intern Med. 2001;161:15. doi: 10.1001/archinte.161.1.15. [PubMed] [CrossRef] [Google Scholar]

33. Gurish M, Castells M. Mast cells: surface receptors and signal transduction. UpToDate. 2017. http://www.uptodate.com. Accessed 1 Oct 2017.

34. Metcalfe DD, Peavy RD, Gilfillan AM. Mechanisms of mast cell signaling in anaphylaxis. J Allergy Clin Immunol. 2009;124:639–646. doi: 10.1016/j.jaci.2009.08.035. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

35. Strait RT, Morris SC, Yang M, Qu X-W, Finkelman FD. Pathways of anaphylaxis in the mouse. J Allergy Clin Immunol. 2002;109:658–668. doi: 10.1067/mai.2002.123302. [PubMed] [CrossRef] [Google Scholar]

36. Rivera J, Gilfillan AM. Molecular regulation of mast cell activation. J Allergy Clin Immunol. 2006;117:1214–1225. doi: 10.1016/j.jaci.2006.04.015. [PubMed] [CrossRef] [Google Scholar]

37. Muñoz-Cano R, Pascal M, Bartra J, Picado C, Valero A, Kim D-K, et al. Distinct transcriptome profiles differentiate nonsteroidal anti-inflammatory drug-dependent from nonsteroidal anti-inflammatory drug-independent food-induced anaphylaxis. J Allergy Clin Immunol. 2016;137:137–146. doi: 10.1016/j.jaci.2015.05.042. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

38. Muraro A, Werfel T, Hoffmann-Sommergruber K, Roberts G, Beyer K, Bindslev-Jensen C, et al. EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy. Allergy. 2014;69:1008–1025. doi: 10.1111/all.12429. [PubMed] [CrossRef] [Google Scholar]

39. Worm M, Edenharter G, Ruëff F, Scherer K, Pföhler C, Mahler V, et al. Symptom profile and risk factors of anaphylaxis in Central Europe. Allergy Eur J Allergy Clin Immunol. 2012;67:691–698. doi: 10.1111/j.1398-9995.2012.02795.x. [PubMed] [CrossRef] [Google Scholar]

40. Harduar-Morano L, Simon MR, Watkins S, Blackmore C. Algorithm for the diagnosis of anaphylaxis and its validation using population-based data on emergency department visits for anaphylaxis in Florida. J Allergy Clin Immunol. 2010;126:98–104.e4. doi: 10.1016/j.jaci.2010.04.017. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

41. Tanno LK, Calderon MA, Li J, Casale T, Demoly P. Updating allergy and/or hypersensitivity diagnostic procedures in the WHO ICD-11 revision. J Allergy Clin Immunol Pract. 2016;4:650–657. doi: 10.1016/j.jaip.2016.01.015. [PubMed] [CrossRef] [Google Scholar]

42. Sala-Cunill A, Cardona V. Biomarkers of anaphylaxis, beyond tryptase. Curr Opin Allergy Clin Immunol. 2015;15:329–336. doi: 10.1097/ACI.0000000000000184. [PubMed] [CrossRef] [Google Scholar]

43. Simons FE, Frew AJ, Ansotegui IJ, Bochner BS, Golden DB, Finkelman FD, et al. Risk assessment in anaphylaxis: current and future approaches. J Allergy Clin Immunol. 2007;120:S2–S24. doi: 10.1016/j.jaci.2007.05.001. [PubMed] [CrossRef] [Google Scholar]

44. Simons FE. Anaphylaxis. J Allergy Clin Immunol. 2010;125:S161–S181. doi: 10.1016/j.jaci.2009.12.981. [PubMed] [CrossRef] [Google Scholar]

45. Mayorga C, Celik G, Rouzaire P, Whitaker P, Bonadonna P, Rodrigues-Cernadas J, et al. In vitro tests for drug hypersensitivity reactions: an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy. 2016;71:1103–1134. doi: 10.1111/all.12886. [PubMed] [CrossRef] [Google Scholar]

46. Ansley L, Bonini M, Delgado L, Del Giacco S, Du Toit G, Khaitov M, et al. Pathophysiological mechanisms of exercise-induced anaphylaxis: an EAACI position statement. Allergy Eur J Allergy Clin Immunol. 2015;70:1212–1221. doi: 10.1111/all.12677. [PubMed] [CrossRef] [Google Scholar]

47. Palosuo K, Varjonen E, Nurkkala J, Kalkkinen N, Harvima R, Reunala T, et al. Transglutaminase-mediated cross-linking of a peptic fraction of ω-5 gliadin enhances IgE reactivity in wheat-dependent, exercise-induced anaphylaxis. J Allergy Clin Immunol. 2003;111:1386–1392. doi: 10.1067/mai.2003.1498. [PubMed] [CrossRef] [Google Scholar]

48. Muñoz-Cano RM, Bartra J, Picado C, Valero A. Mechanisms of anaphylaxis beyond IgE. J Invest Allergol Clin Immunol. 2016;26:73–82. doi: 10.18176/jiaci.0046. [PubMed] [CrossRef] [Google Scholar]

49. Dhami S, Panesar SS, Roberts G, Muraro A, Worm M, Bilò MB, et al. Management of anaphylaxis: a systematic review. Allergy. 2014;69:168–175. doi: 10.1111/all.12318. [PubMed] [CrossRef] [Google Scholar]

50. Simons FER, Ebisawa M, Sanchez-Borges M, Thong BY, Worm M, Tanno LK, et al. 2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines. World Allergy Organ J. 2015;8:32. doi: 10.1186/s40413-015-0080-1. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

51. Dhami S, Sheikh A, Muraro A, Roberts G, Halken S, Fernandez Rivas M, et al. Quality indicators for the acute and long-term management of anaphylaxis: a systematic review. Clin Transl Allergy. 2017;7:15. doi: 10.1186/s13601-017-0151-1. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

52. Pumphrey RSH. Fatal posture in anaphylactic shock. J Allergy Clin Immunol. 2003;112:451–452. doi: 10.1067/mai.2003.1614. [PubMed] [CrossRef] [Google Scholar]

53. Soar J, Pumphrey R, Cant A, Clarke S, Corbett A, Dawson P, et al. Emergency treatment of anaphylactic reactions—guidelines for healthcare providers. Resuscitation. 2008;77:157–169. doi: 10.1016/j.resuscitation.2008.02.001. [PubMed] [CrossRef] [Google Scholar]

54. Tole JW, Lieberman P. Biphasic anaphylaxis: review of incidence, clinical predictors, and observation recommendations. Immunol Allergy Clin N Am. 2007;27:309–326. doi: 10.1016/j.iac.2007.03.011. [PubMed] [CrossRef] [Google Scholar]

55. Lee S, Bellolio MF, Hess EP, Erwin P, Murad MH, Campbell RL. Time of onset and predictors of biphasic anaphylactic reactions: a systematic review and meta-analysis. J Allergy Clin Immunol Pract. 2015;3:408–416e2. doi: 10.1016/j.jaip.2014.12.010. [PubMed] [CrossRef] [Google Scholar]

56. Simons FE, Sheikh A. Evidence-based management of anaphylaxis. Allergy. 2007;62:827–829. doi: 10.1111/j.1398-9995.2007.01433.x. [PubMed] [CrossRef] [Google Scholar]

57. Simons FER. Pharmacologic treatment of anaphylaxis: can the evidence base be strengthened? Curr Opin Allergy Clin Immunol. 2010;10:384–393. doi: 10.1097/ACI.0b013e32833c2038. [PubMed] [CrossRef] [Google Scholar]

58. Sheikh A, Ten Broek V, Brown SG, Simons FE. H1-antihistamines for the treatment of anaphylaxis: Cochrane systematic review. Allergy. 2007;62:830–837. doi: 10.1111/j.1398-9995.2007.01435.x. [PubMed] [CrossRef] [Google Scholar]

59. Simons KJ, Simons FE. Epinephrine and its use in anaphylaxis: current issues. Curr Opin Allergy Clin Immunol. 2010;10:354–361. doi: 10.1097/ACI.0b013e32833bc670. [PubMed] [CrossRef] [Google Scholar]

60. Kemp SF, Lockey RF, Simons FE. Epinephrine: the drug of choice for anaphylaxis. A statement of the World Allergy Organization. Allergy. 2008;63:1061–1070. doi: 10.1111/j.1398-9995.2008.01733.x. [PubMed] [CrossRef] [Google Scholar]

61. McLean-Tooke APC, Bethune CA, Fay AC, Spickett GP. Adrenaline in the treatment of anaphylaxis: what is the evidence? BMJ. 2003;327:1332–1335. doi: 10.1136/bmj.327.7427.1332. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

62. Brown SGA. Cardiovascular aspects of anaphylaxis: implications for treatment and diagnosis. Curr Opin Allergy Clin Immunol. 2005;5:359–364. doi: 10.1097/01.all.0000174158.78626.35. [PubMed] [CrossRef] [Google Scholar]

63. Anchor J, Settipane RA. Appropriate use of epinephrine in anaphylaxis. Am J Emerg Med. 2004;22:488–490. doi: 10.1016/j.ajem.2004.07.016. [PubMed] [CrossRef] [Google Scholar]

64. Fleming JT, Clark S, Camargo CA, Rudders SA. Early treatment of food-induced anaphylaxis with epinephrine is associated with a lower risk of hospitalization. J Allergy Clin Immunol Pract. 2015;3:57–62. doi: 10.1016/j.jaip.2014.07.004. [PubMed] [CrossRef] [Google Scholar]

65. Xu YS, Kastner M, Harada L, Xu A, Salter J, Waserman S. Anaphylaxis-related deaths in Ontario: a retrospective review of cases from 1986 to 2011. Allergy Asthma Clin Immunol. 2014;10:38. doi: 10.1186/1710-1492-10-38. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

66. Simons FE, Roberts JR, Gu X, Simons KJ. Epinephrine absorption in children with a history of anaphylaxis. J Allergy Clin Immunol. 1998;101:33–37. doi: 10.1016/S0091-6749(98)70190-3. [PubMed] [CrossRef] [Google Scholar]

67. Simons FE, Gu X, Simons KJ. Epinephrine absorption in adults: intramuscular versus subcutaneous injection. J Allergy Clin Immunol. 2001;108:871–873. doi: 10.1067/mai.2001.119409. [PubMed] [CrossRef] [Google Scholar]

68. Campbell RL, Bellolio MF, Knutson BD, Bellamkonda VR, Fedko MG, Nestler DM, et al. Epinephrine in anaphylaxis: higher risk of cardiovascular complications and overdose after administration of intravenous bolus epinephrine compared with intramuscular epinephrine. J Allergy Clin Immunol Pract. 2015;3:76–80. doi: 10.1016/j.jaip.2014.06.007. [PubMed] [CrossRef] [Google Scholar]

69. Manivannan V, Campbell RL, Bellolio MF, Stead LG, Li JTC, Decker WW. Factors associated with repeated use of epinephrine for the treatment of anaphylaxis. Ann Allergy Asthma Immunol. 2009;103:395–400. doi: 10.1016/S1081-1206(10)60358-4. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

70. Korenblat P, Lundie MJ, Dankner RE, Day JH. A retrospective study of epinephrine administration for anaphylaxis: how many doses are needed? Allergy Asthma Proc. 1999;20:383–386. doi: 10.2500/108854199778251834. [PubMed] [CrossRef] [Google Scholar]

71. Järvinen KM, Sicherer SH, Sampson HA, Nowak-Wegrzyn A. Use of multiple doses of epinephrine in food-induced anaphylaxis in children. J Allergy Clin Immunol. 2008;122:133–138. doi: 10.1016/j.jaci.2008.04.031. [PubMed] [CrossRef] [Google Scholar]

72. Bautista E, Simons FER, Simons KJ, Becker AB, Duke K, Tillett M, et al. Epinephrine fails to hasten hemodynamic recovery in fully developed canine anaphylactic shock. Int Arch Allergy Immunol. 2002;128:151–164. doi: 10.1159/000059406. [PubMed] [CrossRef] [Google Scholar]

73. Simons FER. First-aid treatment of anaphylaxis to food: focus on epinephrine. J Allergy Clin Immunol. 2004;113:837–844. [PubMed] [Google Scholar]

74. Kanwar M, Irvin CB, Frank JJ, Weber K, Rosman H. Confusion about epinephrine dosing leading to iatrogenic overdose: a life-threatening problem with a potential solution. Ann Emerg Med. 2010;55:341–344. doi: 10.1016/j.annemergmed.2009.11.008. [PubMed] [CrossRef] [Google Scholar]

75. Sicherer SH, Simons FER. Epinephrine for first-aid management of anaphylaxis. Pediatrics. 2017;139:e20164006. doi: 10.1542/peds.2016-4006. [PubMed] [CrossRef] [Google Scholar]

76. Lieberman P, Simons FER. Anaphylaxis and cardiovascular disease: therapeutic dilemmas. Clin Exp Allergy. 2015;45:1288–1295. doi: 10.1111/cea.12520. [PubMed] [CrossRef] [Google Scholar]

77. Triggiani M, Patella V, Staiano RI, Granata F, Marone G. Allergy and the cardiovascular system. Clin Exp Immunol. 2008;153:7–11. doi: 10.1111/j.1365-2249.2008.03714.x. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

78. Choo KJ, Simons E, Sheikh A. Glucocorticoids for the treatment of anaphylaxis: Cochrane systematic review. Allergy. 2010;65:1205–1211. doi: 10.1111/j.1398-9995.2010.02424.x. [PubMed] [CrossRef] [Google Scholar]

79. Nurmatov UB, Rhatigan E, Simons FER, Sheikh A. H2-antihistamines for the treatment of anaphylaxis with and without shock: a systematic review. Ann Allergy Asthma Immunol. 2014;112:126–131. doi: 10.1016/j.anai.2013.11.010. [PubMed] [CrossRef] [Google Scholar]

80. Boyce JA, Assa’ad A, Burks AW, Jones SM, Sampson HA, NIAID-Sponsored Expert Panel JA et al. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol. 2010;126:S1–S58. doi: 10.1016/j.jaci.2010.10.008. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

81. Park JH, Godbold JH, Chung D, Sampson HA, Wang J. Comparison of cetirizine and diphenhydramine in the treatment of acute food-induced allergic reactions. J Allergy Clin Immunol. 2011;128:1127–1128. doi: 10.1016/j.jaci.2011.08.026. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

82. Lin RY, Curry A, Pesola GR, Knight RJ, Lee HS, Bakalchuk L, et al. Improved outcomes in patients with acute allergic syndromes who are treated with combined H1 and H2 antagonists. Ann Emerg Med. 2000;36:462–468. doi: 10.1016/S0196-0644(00)43749-2. [PubMed] [CrossRef] [Google Scholar]

83. Waserman S, Chad Z, Francoeur MJ, Small P, Stark D, Vander Leek TK, et al. Management of anaphylaxis in primary care: Canadian expert consensus recommendations. Allergy Eur J Allergy Clin Immunol. 2010;65:1082–1092. [PubMed] [Google Scholar]

84. Campbell RL, Park MA, Kueber MA, Lee S, Hagan JB. Outcomes of allergy/immunology follow-up after an emergency department evaluation for anaphylaxis. J Allergy Clin Immunol Pract. 2015;3:88–93. doi: 10.1016/j.jaip.2014.07.011. [PubMed] [CrossRef] [Google Scholar]

85. Alvarez-Perea A, Ameiro B, Morales C, Zambrano G, Rodriguez A, Guzman M, et al. Anaphylaxis in the Pediatric Emergency Department: analysis of 133 cases after an allergy workup. J Allergy Clin Immunol Pract. 2017;5:1256–1263. doi: 10.1016/j.jaip.2017.02.011. [PubMed] [CrossRef] [Google Scholar]

86. Altman AM, Camargo CAJ, Simons FER, Lieberman PPL, Sampson HA, Schwartz LB, et al. Risk factors for severe anaphylaxis in patients receiving anaphylaxis treatment in US emergency departments and hospitals. J Allergy Clin Immunol. 2014;127:461–467. [Google Scholar]

87. Castells MC. A new era for drug desensitizations. J Allergy Clin Immunol Pract. 2015;3:639–640. doi: 10.1016/j.jaip.2015.05.006. [PubMed] [CrossRef] [Google Scholar]

88. Alfaya Arias T, Soriano Gómis V, Soto Mera T, Vega Castro A, Vega Gutiérrez J, Alonso Llamazares A, et al. Key issues in hymenoptera venom allergy: an update. J Invest Allergol Clin Immunol. 2017;27:19–31. doi: 10.18176/jiaci.0123. [PubMed] [CrossRef] [Google Scholar]

89. Nurmatov U, Dhami S, Arasi S, Pajno GB, Fernandez-Rivas M, Muraro A, et al. Allergen immunotherapy for IgE-mediated food allergy: a systematic review and meta-analysis. Allergy. 2017;72:1133–1147. doi: 10.1111/all.13124. [PubMed] [CrossRef] [Google Scholar]

90. El-Qutob D. Off-label uses of omalizumab. Clin Rev Allergy Immunol. 2016;50:84–96. doi: 10.1007/s12016-015-8490-y. [PubMed] [CrossRef] [Google Scholar]

91. Wang J, Sicherer SH. Guidance on completing a written allergy and anaphylaxis emergency plan. Pediatrics. 2017;139:e20164005. doi: 10.1542/peds.2016-4005. [PubMed] [CrossRef] [Google Scholar]

92. Campbell R, Bellolio M, Motosue M, Sunga K, Lohse C, Rudis M. Autoinjectors preferred for intramuscular epinephrine in anaphylaxis and allergic reactions. West J Emerg Med. 2016;172:775–782. doi: 10.5811/westjem.2016.8.30505. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

93. Niggemann B, Beyer K. Adrenaline autoinjectors in food allergy: in for a cent, in for a euro? Pediatr Allergy Immunol. 2012;23:506–508. doi: 10.1111/j.1399-3038.2012.01300.x. [PubMed] [CrossRef] [Google Scholar]

94. Pinczower GD, Bertalli NA, Bussmann N, Hamidon M, Allen KJ, Dunngalvin A, et al. The effect of provision of an adrenaline autoinjector on quality of life in children with food allergy. J Allergy Clin Immunol. 2013;131:238–241. doi: 10.1016/j.jaci.2012.09.038. [PubMed] [CrossRef] [Google Scholar]

95. Brockow K, Schallmayer S, Beyer K, Biedermann T, Fischer J, Gebert N, et al. Effects of a structured educational intervention on knowledge and emergency management in patients at risk for anaphylaxis. Allergy. 2015;70:227–235. doi: 10.1111/all.12548. [PubMed] [CrossRef] [Google Scholar]

96. Salter SM, Vale S, Sanfilippo FM, Loh R, Clifford RM. Long-term effectiveness of online anaphylaxis education for pharmacists. Am J Pharm Educ. 2014;78:136. doi: 10.5688/ajpe787136. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

97. Lee K, Hoti K, Hughes JD, Emmerton LM, Platt T. Interventions to assist health consumers to find reliable online health information: a comprehensive review. PLoS ONE. 2014;9:e94186. doi: 10.1371/journal.pone.0094186. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

98. Gallagher M, Worth A, Cunningham-Burley S, Sheikh A. Strategies for living with the risk of anaphylaxis in adolescence: qualitative study of young people and their parents. Prim Care Respir J. 2012;21:392–397. doi: 10.4104/pcrj.2012.00072. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

99. D’Amato G, Vitale C, Mormile M, Vatrella A, D’Amato M. The impact of social and digital media on asthmatic adolescents. Pediatr Allergy Immunol. 2016;27:650–651. doi: 10.1111/pai.12581. [PubMed] [CrossRef] [Google Scholar]

100. González-de-Olano D, Botella-Padilla I. Respiratory allergy buzz on the Internet. J Allergy Clin Immunol Pract. 2017;5:187–188. doi: 10.1016/j.jaip.2016.08.009. [PubMed] [CrossRef] [Google Scholar]

101. Simons FER, Sampson HA. Anaphylaxis: unique aspects of clinical diagnosis and management in infants (birth to age 2 years) J Allergy Clin Immunol. 2015;135:1125–1131. doi: 10.1016/j.jaci.2014.09.014. [PubMed] [CrossRef] [Google Scholar]

102. Muraro A, Roberts G, Clark A, Eigenmann PA, Halken S, Lack G, et al. The management of anaphylaxis in childhood: position paper of the European academy of allergology and clinical immunology. Allergy. 2007;62:857–871. doi: 10.1111/j.1398-9995.2007.01421.x. [PubMed] [CrossRef] [Google Scholar]

103. Sicherer SH, Mahr T. American Academy of Pediatrics Section on Allergy and Immunology. Management of food allergy in the school setting. Pediatrics. 2010;126:1232–1239. doi: 10.1542/peds.2010-2575. [PubMed] [CrossRef] [Google Scholar]

104. Muraro A, Clark A, Beyer K, Borrego LM, Borres M, Lødrup Carlsen KC, et al. The management of the allergic child at school: EAACI/GA2LEN Task Force on the allergic child at school. Allergy. 2010;65:681–689. doi: 10.1111/j.1398-9995.2010.02343.x. [PubMed] [CrossRef] [Google Scholar]

105. Polloni L, Lazzarotto F, Toniolo A, Ducolin G, Muraro A. What do school personnel know, think and feel about food allergies? Clin Transl Allergy. 2013;3:39. doi: 10.1186/2045-7022-3-39. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

106. Muraro A, Agache I, Clark A, Sheikh A, Roberts G, Akdis CA, et al. EAACI Food Allergy and Anaphylaxis Guidelines: managing patients with food allergy in the community. Allergy. 2014;69:1046–1057. doi: 10.1111/all.12441. [PubMed] [CrossRef] [Google Scholar]

107. Monks H, Gowland MH, MacKenzie H, Erlewyn-Lajeunesse M, King R, Lucas JS, et al. How do teenagers manage their food allergies? Clin Exp Allergy. 2010;40:1533–1540. doi: 10.1111/j.1365-2222.2010.03586.x. [PubMed] [CrossRef] [Google Scholar]

108. MacKenzie H, Roberts G, Van Laar D, Dean T. Teenagers’ experiences of living with food hypersensitivity: a qualitative study. Pediatr Allergy Immunol. 2009;21:595–602. doi: 10.1111/j.1399-3038.2009.00938.x. [PubMed] [CrossRef] [Google Scholar]

109. Sampson MA, Muñoz-Furlong A, Sicherer SH. Risk-taking and coping strategies of adolescents and young adults with food allergy. J Allergy Clin Immunol. 2006;117:1440–1445. doi: 10.1016/j.jaci.2006.03.009. [PubMed] [CrossRef] [Google Scholar]

110. Gallagher M, Worth A, Cunningham-Burley S, Sheikh A. Epinephrine auto-injector use in adolescents at risk of anaphylaxis: a qualitative study in Scotland, UK. Clin Exp Allergy. 2011;41:869–877. doi: 10.1111/j.1365-2222.2011.03743.x. [PubMed] [CrossRef] [Google Scholar]

111. Ventura MT, Scichilone N, Gelardi M, Patella V, Ridolo E. Management of allergic disease in the elderly: key considerations, recommendations and emerging therapies. Expert Rev Clin Immunol. 2015;11:1219–1228. doi: 10.1586/1744666X.2015.1081564. [PubMed] [CrossRef] [Google Scholar]

112. González-de-Olano D, Lombardo C, González-Mancebo E. The difficult management of anaphylaxis in the elderly. Curr Opin Allergy Clin Immunol. 2016;16:352–360. doi: 10.1097/ACI.0000000000000280. [PubMed] [CrossRef] [Google Scholar]

113. González De Olano D, De La Hoz Caballer B, Núñez López R, Sánchez Muñoz L, Cuevas Agustín M, Diéguez MC, et al. Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain: a study of the Spanish network on mastocytosis (REMA) Clin Exp Allergy. 2007;37:1547–1555. [PubMed] [Google Scholar]

114. Prieto-García A, Álvarez-Perea A, Matito A, Sánchez-Muñoz L, Morgado JM, Escribano L, et al. Systemic mastocytosis presenting as IgE-mediated food-induced anaphylaxis: a report of two cases. J Allergy Clin Immunol Pract. 2015;3:456–458. doi: 10.1016/j.jaip.2015.01.011. [PubMed] [CrossRef] [Google Scholar]

115. Schuch A, Brockow K. Mastocytosis and anaphylaxis. Immunol Allergy Clin N Am. 2017;37:153–164. doi: 10.1016/j.iac.2016.08.017. [PubMed] [CrossRef] [Google Scholar]

116. Gülen T, Ljung C, Nilsson G, Akin C, Nilsson G, Noel P, et al. Risk factor analysis of anaphylactic reactions in patients with systemic mastocytosis. J Allergy Clin Immunol Pract. 2017;44:1179–1187. [PubMed] [Google Scholar]